Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upexi (UPXI) Cash & Equivalents (2020 - 2025)

Historic Cash & Equivalents for Upexi (UPXI) over the last 6 years, with Q3 2025 value amounting to $2.2 million.

  • Upexi's Cash & Equivalents rose 2495.72% to $2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year increase of 2495.72%. This contributed to the annual value of $3.0 million for FY2025, which is 34981.59% up from last year.
  • Upexi's Cash & Equivalents amounted to $2.2 million in Q3 2025, which was up 2495.72% from $3.0 million recorded in Q2 2025.
  • Upexi's Cash & Equivalents' 5-year high stood at $14.5 million during Q2 2021, with a 5-year trough of $224318.0 in Q1 2024.
  • Its 5-year average for Cash & Equivalents is $3.7 million, with a median of $2.2 million in 2025.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first surged by 246084.46% in 2021, then tumbled by 8743.0% in 2023.
  • Over the past 5 years, Upexi's Cash & Equivalents (Quarter) stood at $6.6 million in 2021, then crashed by 31.65% to $4.5 million in 2022, then tumbled by 87.43% to $566677.0 in 2023, then fell by 28.29% to $406347.0 in 2024, then surged by 450.57% to $2.2 million in 2025.
  • Its Cash & Equivalents was $2.2 million in Q3 2025, compared to $3.0 million in Q2 2025 and $230392.0 in Q1 2025.